Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163.

Hashizume R, Ozawa T, Gryaznov SM, Bollen AW, Lamborn KR, Frey WH 2nd, Deen DF.

Neuro Oncol. 2008 Apr;10(2):112-20. doi: 10.1215/15228517-2007-052. Epub 2008 Feb 20.

2.

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.

Günther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K.

Oncogene. 2008 May 1;27(20):2897-909. Epub 2007 Nov 26.

PMID:
18037961
3.

Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy.

Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, Berger MS, James CD.

J Neurosurg. 2007 Sep;107(3):610-6.

PMID:
17886562
4.

Brainstem tumors: where are we today?

Recinos PF, Sciubba DM, Jallo GI.

Pediatr Neurosurg. 2007;43(3):192-201. Review.

PMID:
17409788
5.

Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.

Sarkaria JN, Yang L, Grogan PT, Kitange GJ, Carlson BL, Schroeder MA, Galanis E, Giannini C, Wu W, Dinca EB, James CD.

Mol Cancer Ther. 2007 Mar;6(3):1167-74.

6.

Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model.

Kang SH, Cho HT, Devi S, Zhang Z, Escuin D, Liang Z, Mao H, Brat DJ, Olson JJ, Simons JW, Lavallee TM, Giannakakou P, Van Meir EG, Shim H.

Cancer Res. 2006 Dec 15;66(24):11991-7.

7.

A novel brainstem tumor model: functional and histopathological characterization.

Jallo GI, Volkov A, Wong C, Carson BS Sr, Penno MB.

Childs Nerv Syst. 2006 Dec;22(12):1519-25. Epub 2006 Oct 5.

PMID:
17021732
8.

Response of intracerebral human glioblastoma xenografts to multifraction radiation exposures.

Ozawa T, Faddegon BA, Hu LJ, Bollen AW, Lamborn KR, Deen DF.

Int J Radiat Oncol Biol Phys. 2006 Sep 1;66(1):263-70.

PMID:
16904526
9.

Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporter.

Hasegawa K, Pham L, O'Connor MK, Federspiel MJ, Russell SJ, Peng KW.

Clin Cancer Res. 2006 Mar 15;12(6):1868-75.

10.

Barriers to carrier mediated drug and gene delivery to brain tumors.

Huynh GH, Deen DF, Szoka FC Jr.

J Control Release. 2006 Jan 10;110(2):236-59. Epub 2005 Nov 28. Review.

PMID:
16318895
12.

A novel brainstem tumor model: guide screw technology with functional, radiological, and histopathological characterization.

Lee J, Jallo GI, Guarnieri M, Carson BS Sr, Penno MB.

Neurosurg Focus. 2005 Jun 15;18(6A):E11.

PMID:
16048287
13.

In vivo evaluation of the boronated porphyrin TABP-1 in U-87 MG intracerebral human glioblastoma xenografts.

Ozawa T, Santos RA, Lamborn KR, Bauer WF, Koo MS, Kahl SB, Deen DF.

Mol Pharm. 2004 Sep-Oct;1(5):368-74.

PMID:
16026007
14.

Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Giannini C, Sarkaria JN, Saito A, Uhm JH, Galanis E, Carlson BL, Schroeder MA, James CD.

Neuro Oncol. 2005 Apr;7(2):164-76.

15.

Experimental models of brainstem tumors: development of a neonatal rat model.

Jallo GI, Penno M, Sukay L, Liu JY, Tyler B, Lee J, Carson BS, Guarnieri M.

Childs Nerv Syst. 2005 May;21(5):399-403. Epub 2005 Feb 9.

PMID:
15702357
16.

Spying on cancer: molecular imaging in vivo with genetically encoded reporters.

Gross S, Piwnica-Worms D.

Cancer Cell. 2005 Jan;7(1):5-15. Review.

17.

Role of temozolomide after radiotherapy for newly diagnosed diffuse brainstem glioma in children: results of a multiinstitutional study (SJHG-98).

Broniscer A, Iacono L, Chintagumpala M, Fouladi M, Wallace D, Bowers DC, Stewart C, Krasin MJ, Gajjar A.

Cancer. 2005 Jan 1;103(1):133-9.

18.

Comparison of vitamins K1, K2 and K3 effects on growth of rat glioma and human glioblastoma multiforme cells in vitro.

Oztopçu P, Kabadere S, Mercangoz A, Uyar R.

Acta Neurol Belg. 2004 Sep;104(3):106-10.

PMID:
15508263
19.

Comparison of the antiproliferative properties of antiestrogenic drugs (nafoxidine and clomiphene) on glioma cells in vitro.

Yaz G, Kabadere S, Oztopçu P, Durmaz R, Uyar R.

Am J Clin Oncol. 2004 Aug;27(4):384-8.

PMID:
15289732
20.

Antitumor effects of specific telomerase inhibitor GRN163 in human glioblastoma xenografts.

Ozawa T, Gryaznov SM, Hu LJ, Pongracz K, Santos RA, Bollen AW, Lamborn KR, Deen DF.

Neuro Oncol. 2004 Jul;6(3):218-26.

Supplemental Content

Support Center